Johnson & Johnson to Buy Firefly Bio for $1 Billion Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline. Post navigation Previous Previous post: Justin Cooper Update: “I got a concussion and the body is beat up, but thankful everything else checked out okay”Next Next post: Some Lunatic Is Putting A Turbo Onto a Harbor Freight Motor. Plans Insane Go-Kart Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News 5 Features The iPad Pro Has That An iPad Air Doesn’t 0 Here is how to watch Apple’s WWDC 2026 conference where iOS 27 is expected 0
